Evidence map›Paper›PMID 31341163›Full record

ArticleNature communications2019

ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP.

Francesca Bufalieri, Paola Infante, Flavia Bernardi, Miriam Caimano, Paolo Romania, Marta Moretti, Ludovica Lospinoso Severini, Julie Talbot, Ombretta Melaiu, Mirella Tanori and 17 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Targeting USP47 reprograms macrophage polarization to ameliorate septic peritonitis and promote cutaneous wound healing.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. American journal of respiratory and critical care medicine · 2024
    Article
  10. Review
  11. Review
  12. SALL4 is a CRL3Cell death and differentiation · 2024
    Article
  13. Exploring the neuropharmacological properties of scopoletin-richAmerican journal of translational research · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Expression of FBXW11 in normal and disease-associated osteogenic cells.Journal of cellular and molecular medicine · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 12 institutions in 4 countries.

Francesca BufalieriDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.ORCID http://orcid.org/0000-0002-9571-318X
Paola InfanteCenter for Life NanoScience@Sapienza, Istituto Italiano di Tecnologia, 00161, Rome, Italy.
Flavia BernardiDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.
Miriam CaimanoDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.
Paolo RomaniaPaediatric Haematology/Oncology Department, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Marta MorettiDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.
Ludovica Lospinoso SeveriniDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.
Julie TalbotInstitut Curie, PSL Research University, CNRS UMR, INSERM, 91405, Orsay, France.
Ombretta MelaiuPaediatric Haematology/Oncology Department, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Mirella TanoriLaboratory of Biomedical Technologies, Agenzia Nazionale per le Nuove Tecnologie, l'Energia e lo Sviluppo Economico Sostenibile (ENEA), S.Maria di Galeria, 00123, Rome, Italy.
Laura Di MagnoCenter for Life NanoScience@Sapienza, Istituto Italiano di Tecnologia, 00161, Rome, Italy.
Diana BellaviaDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.
Carlo CapalboDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.ORCID http://orcid.org/0000-0001-8445-6782
Stéphanie PugetDepartment of Pediatric Neurosurgery, Necker University Hospital, University Paris Descartes, Sorbonne Paris Cité, 75015, Paris, France.
Enrico De SmaeleDepartment of Experimental Medicine, University La Sapienza, 00161, Rome, Italy.ORCID http://orcid.org/0000-0003-4524-4423
Gianluca CanettieriDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.
Daniele GuardavaccaroDepartment of Biotechnology, University of Verona, 37134, Verona, Italy.
Luca BusinoDepartment of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104, PA, USA.ORCID http://orcid.org/0000-0001-6758-9276
Angelo PeschiaroliNational Research Council of Italy CNR, Institute of Translational Pharmacology (IFT), 00133, Rome, Italy.
Simonetta PazzagliaLaboratory of Biomedical Technologies, Agenzia Nazionale per le Nuove Tecnologie, l'Energia e lo Sviluppo Economico Sostenibile (ENEA), S.Maria di Galeria, 00123, Rome, Italy.
Giuseppe GianniniDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.
Gerry MelinoMRC Toxicology Unit, University of Cambridge, LE17HB, Leiicester, UK.ORCID http://orcid.org/0000-0001-9428-5972
Franco LocatelliPaediatric Haematology/Oncology Department, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Alberto GulinoDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy.
Olivier AyraultInstitut Curie, PSL Research University, CNRS UMR, INSERM, 91405, Orsay, France.
Doriana FruciPaediatric Haematology/Oncology Department, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy. doriana.fruci@opbg.net.ORCID http://orcid.org/0000-0003-3388-7296
Lucia Di MarcotullioDepartment of Molecular Medicine, University La Sapienza, 00161, Rome, Italy. lucia.dimarcotullio@uniroma1.it.
Sapienza University of Rome · ITUniversité Paris-Sud · FRBambino Gesù Children's Hospital · ITIstituto Pasteur · ITItalian Institute of Technology · ITNational Agency for New Technologies, Energy and Sustainable Economic Development · ITDélégation Paris 5 · FRIstituto di Farmacologia Traslazionale · ITUniversity of Pennsylvania · USUniversity of Pisa · ITUniversity of Rome Tor Vergata · ITUniversity of Verona · IT

Funding

Medical Research Council MC_U132670600Medical Research Council MC_UU_00025/2
6 · The paper itself

Abstract

The Hedgehog (Hh) pathway is essential for embryonic development and tissue homeostasis. Aberrant Hh signaling may occur in a wide range of human cancers, such as medulloblastoma, the most common brain malignancy in childhood. Here, we identify endoplasmic reticulum aminopeptidase 1 (ERAP1), a key regulator of innate and adaptive antitumor immune responses, as a previously unknown player in the Hh signaling pathway. We demonstrate that ERAP1 binds the deubiquitylase enzyme USP47, displaces the USP47-associated βTrCP, the substrate-receptor subunit of the SCF

Indexed as

AminopeptidasesAnimalsbeta-Transducin Repeat-Containing ProteinsCarcinogenesisHedgehog ProteinsMiceMinor Histocompatibility AntigensNIH 3T3 CellsProtein StabilityProteolysisSignal TransductionUbiquitin-Specific ProteasesAminopeptidasesbeta-Transducin Repeat-Containing ProteinsERAP1 protein, mouseHedgehog ProteinsMinor Histocompatibility AntigensUbiquitin-Specific ProteasesUsp47 protein, mouse

Identifiers

PMID31341163
PMCPMC6656771
OpenAlexW2963123473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.